![John DeYoung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John DeYoung
Directeur/Membre du Conseil chez
ALLOGENE THERAPEUTICS, INC.
Profil
John DeYoung is currently an Independent Director at Allogene Therapeutics, Inc. since 2018.
Mr. DeYoung is also Vice President-Worldwide Business Development at Pfizer Inc. since 2009.
Mr. DeYoung completed an undergraduate degree at Michigan State University in 1985.
Mr. DeYoung earned an MBA from The University of Chicago in 1990.
Postes actifs de John DeYoung
| Sociétés | Poste | Début |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/04/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/12/2009 |
Formation de John DeYoung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
